Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Vbi Vaccines Inc CS (NQ: VBIV )

3.090 USD +0.110 (+3.69%)
Official Closing Price Updated: 7:59 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,633,100
Open 3.060
Bid (Size) 3.090 (9)
Ask (Size) 3.120 (7)
Prev. Close 2.980
Today's Range 2.680 - 3.100
52wk Range 0.6900 - 6.930
Shares Outstanding 64,078,781
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2020, Provides Corporate Update and Outlook for 2021
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced financial results for the fourth... 
From Business Wire News Releases
VBI Vaccines to Present at the Raymond James 42nd Annual Institutional Investors Conference
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Jeff Baxter, President and... 
From Business Wire News Releases

Performance

YTD
+5.46%
+5.46%
1 Month
-16.71%
-16.71%
3 Month
-3.74%
-3.74%
6 Month
-6.93%
-6.93%
1 Year
+137.69%
+137.69%

More News

Read More
VBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBI’s 3-Antigen Prophylactic Hepatitis B Vaccine
From Business Wire News Releases
VBI Vaccines Announces Progress of Coronavirus Vaccine Program
From Business Wire News Releases
Recent Challenges Demand Innovative Approaches to Surface Disinfections
From PR Newswire
VBI Vaccines Announces Publication of Results from a Phase 4 Study of VBI’s Prophylactic 3-Antigen Hepatitis B Vaccine in Vaccine
From Business Wire News Releases
VBI Vaccines Announces European Medicines Agency Acceptance of Marketing Authorization Application (MAA) for 3-Antigen Prophylactic Hepatitis B Vaccine
From Business Wire News Releases
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
Tags AMRN Benzinga EKSO
From Benzinga
VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine
From Business Wire News Releases
10 Health Care Stocks With Unusual Options Alerts In Today's Session
Tags VBIV BZI/AUOA Market News
From Benzinga
Why Novartis, BioVie, Esperion And VBI Are Moving Today
Tags Trading Ideas News why it's moving
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.